Why is Emmessar Biotech falling/rising?

As of 30-Oct, Emmessar Biotech & Nutrition Ltd is experiencing a decline in its stock price, currently at Rs 29.56, which represents a decrease of Rs 1.44 or 4.65%. The stock has underperformed its sector by 4.23% today, reaching an intraday low of Rs 29.46. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also significantly decreased, falling by 58.12% compared to the 5-day average, suggesting a drop in investor participation. Over the past week, the stock has declined by 8.77%, and year-to-date, it has fallen by 36.16%, contrasting sharply with the Sensex, which has gained 8.02% during the same period.
In the broader market context, Emmessar Biotech's performance has been notably weaker than the benchmark index, particularly in the short term, where it has underperformed by a significant margin. While the Sensex has shown a slight decline of 0.18% over the past week, Emmessar Biotech's substantial drop indicates a lack of confidence among investors. The stock's long-term performance over three years shows a positive return of 37.17%, but this is overshadowed by its year-to-date and one-year declines, which suggest ongoing challenges for the company amidst a generally positive market environment.